- $68.23bn
- $86.43bn
- $14.09bn
- 89
- 36
- 54
- 63
Annual balance sheet for CSX, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | R2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | 10-K | 10-K | 10-Q | 10-K | 8-K |
| Standards: | USG | USG | USG | USG | — |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 2,316 | 2,087 | 1,436 | 1,005 | 675 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 1,148 | 1,313 | 1,393 | 1,326 | — |
| Total Inventory | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 3,873 | 3,849 | 3,359 | 2,820 | 2,550 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 33,516 | 34,747 | 35,219 | 36,145 | 36,811 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Other Long Term Assets | |||||
| Total Assets | 40,531 | 41,912 | 42,212 | 42,764 | 43,682 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 2,233 | 2,471 | 3,223 | 3,276 | 3,133 |
| Long Term Debt | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Funded Status | |||||
| Total Liabilities | 27,041 | 29,297 | 30,232 | 30,262 | 30,522 |
| Common Stock | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 13,490 | 12,615 | 11,980 | 12,502 | 13,160 |
| Total Liabilities & Shareholders' Equity | 40,531 | 41,912 | 42,212 | 42,764 | 43,682 |
| Total Common Shares Outstanding |